The new powder formulation gives children and adults living with Rett syndrome greater flexibility and choice in dose volume and taste
Abbott is eyeing to become a global powerhouse in early cancer detection and precision oncology
Total income for the period stood at Rs. 7101.28 crore
Panacea Biotec receives Rs. 315 crore LoA from UNICEF
Pegozafermin offers a distinct mechanism of action with potential for enhanced efficacy and tolerability and opportunities for combination development with incretins
This approval follows the CDE’s clearance in July of this year for Phase 2/3 clinical studies of CB03-154 in amyotrophic lateral sclerosis
These orders are from international government tenders in South Africa, Tanzania, and Kenya, as well as from international agencies WHO/UNFPA, NGOs like MSI and PSI
The projected business potential is around US$ 1 million in the first year
The CRDMO segment contributed Rs. 452.7 crore, recording a robust 70.5 per cent YoY increase
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
Subscribe To Our Newsletter & Stay Updated
